top of page
Search


CRX retinopathy project
Dr. Shiming Chen (Opthalmology & Visual Sciences – Washington University) has an exciting new study and is recruiting CRX families.
Jan 28, 2025


WHEN RARE IS RELATIVE
Although the IRD patient population is small compared with other retinal conditions, the research on novel therapeutic approaches is not.
Jul 31, 2024


Progression of PROM1-Associated Retinal Degeneration as Determined by Spectral-Domain Optical Coherence Tomography Over a 24-Month Period
Significant thickness losses could be detected in outer retinal layers by SD-OCT over a 24-month period in patients with PROM1-associated RD
Mar 30, 2024


Identification of a novel compound heterozygous <em>CYP4V2</em> variant in a patient with autosomal recessive retinitis pigmentosa
Aim of present study: screen for possible disease‑causing genetic variants in a non‑consanguineous Chinese family with non‑syndromic arRP.
Mar 14, 2022


Retinitis Pigmentosa Pathway
Many genes have been identified for the inherited and highly heterogeneous disorders - some are arRP, adRP and X-linked.
Jan 1, 2022


The LRAT−/− RAT: CRISPR/Cas9 Construction and Phenotyping of a New Animal Model for RP
Researchers developed and phenotyped a pigmented knockout rat model for lecithin retinol acyltransferase (LRAT) using CRISPR/Cas9.
Jul 5, 2021


Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy
Ana B. Garcia-Delgado , Lourdes Valdes-Sanchez , Maria Jose Morillo-Sanchez , Beatriz Ponte-Zuñiga , Francisco J. Diaz-Corrales , Berta...
May 17, 2021


LCA, early-onset severe retinal dystrophy: current management and clinical trials
RPE65-related LCA pivotal trials, . . . have paved the way for a new era of genetic treatments in ophthalmology.
Mar 12, 2021


Genome Editing in Retinal Diseases using CRISPR Technology
By: Glenn Yiu, MD, PhD - Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, California
Ophthalmology
Mar 7, 2021
All Posts
bottom of page
